AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 29th, 2005 • Celldex Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
ASSET PURCHASE AGREEMENT (this "Agreement"), dated as of January 31, 2005 (the "Execution Date"), by and between Celldex Therapeutics, Inc., a Delaware corporation (including its assignees, (the "Acquirer"), and Alteris Therapeutics, Inc., a Delaware corporation (the "Transferor"; and together with the Acquirer, each, a "Party" and, collectively, the "Parties").
